By Vincent Cruz
Indian beauty is having a real moment in the American market. Ayurvedic oils, herbal face packs, kajal, henna, and neem-based skincare now sell across Amazon, TikTok Shop, and U.S. distributors. Demand is not the problem. The problem is that most Indian brands plan their U.S. entry around Indian rules — and Indian rules end at the border.
This guide is written for the Indian brand owner planning a U.S. launch: what MoCRA requires of you, where Indian and U.S. rules diverge, and the specific mistakes that catch Indian brands. For the full compliance picture, start with the MoCRA Compliance Guide for Cosmetic Brands.
The core rule: Indian compliance does not transfer
Everything in this guide follows from one fact: FDA does not recognize Indian compliance as a substitute for U.S. compliance. Specifically:
- Your CDSCO or state manufacturing licence has no standing with FDA. It proves you can legally make cosmetics in India; it satisfies no U.S. filing requirement.
- Your AYUSH licence for Ayurvedic products means nothing to FDA: the U.S. has no Ayurvedic category at all. Your product is a cosmetic or a drug, and FDA decides which based on your claims, not tradition or ingredients.
- Indian product registration and labelling approvals do not transfer. The U.S. runs its own facility registration and product listing systems.
- Export certificates, including a Certificate of Free Sale, are supporting paperwork for customs and buyers. They are not FDA filings.
Plan your U.S. launch as a fresh compliance project, not an extension of your Indian paperwork.
Step 1: Register your facility with FDA
If your products are manufactured or processed in India (or anywhere outside the U.S.) for sale in America, the facility must register with FDA. Key points for Indian brands:
- You need an FEI number first. The FDA Establishment Identifier is required before registration can be filed. Request it from FDA by email; processing typically takes 7 to 10 business days. Run the free FEI check to see whether your facility already has one.
- Registration is filed through Cosmetics Direct, FDA’s online portal, using Form FDA 5066. The step-by-step process is covered in Cosmetics Direct: How to Register Your Facility.
- Registration renews every two years, based on your facility’s initial registration date, with automated reminders from FDA. See MoCRA Biennial Renewal Explained.
- Using a contract manufacturer? The facility that manufactures the product is the one that registers. If a third-party manufacturer in India makes your products, that facility registers (and it needs its own U.S. agent). See Private Label Cosmetics: Who Registers Under MoCRA.
A common Indian-brand mistake: assuming your U.S. importer’s paperwork covers you. It does not — the manufacturing facility registers, and a distributor cannot register on its behalf.
Step 2: Name a U.S. agent
Every foreign facility registering with FDA must designate a U.S. agent: a person or business physically present in the United States who serves as FDA’s official contact for the facility. This is not optional, and neither an Indian address, a virtual mailbox, nor your U.S. importer can fill the role.
The agent receives FDA correspondence, relays it to you, and is the contact FDA reaches out to with questions about your facility. Our own service is flat pricing: $450 one-time plus $34.99 per month per facility. For how to evaluate providers, see How to Choose a MoCRA U.S. Agent and Who Can Be a MoCRA U.S. Agent.
Step 3: List your products
Each cosmetic product sold in the U.S. must be listed with FDA through Cosmetics Direct (Form FDA 5067), filed by the responsible person — the manufacturer, packer, or distributor whose name appears on the label. Listings include product and ingredient information and must be kept current with annual updates.
Note the difference from India: the U.S. listing is a separate federal filing in a different format, and neither system recognizes the other. For how registration and listing differ, see Facility Registration vs Product Listing Explained.
Step 4: Fix your labels for the U.S. market
Indian labels do not automatically comply with U.S. labeling law. The differences that matter most:
Ingredient declaration. The U.S. uses INCI-style nomenclature, so your ingredient names mostly transfer. But the U.S. requires ingredients in descending order of predominance with specific formatting rules, and FDA is developing fragrance allergen labeling regulations that will add new disclosure requirements.
Net quantity. U.S. consumer commodities must state net quantity in both U.S. customary and metric units, placed in a specific location on the principal display panel. Indian labels showing metric only need updating.
Name and place of business. The label must show the name and place of business of the manufacturer, packer, or distributor. An Indian address alone is acceptable only if the product is not misleading about origin; many Indian brands add their U.S. distributor’s information.
Domestic contact for adverse events. MoCRA requires labels to carry a U.S. domestic contact — address, phone number, or electronic contact such as a website — for adverse-event reports. An India-only contact does not satisfy this.
Language. All required label information must be in English and must be prominent and conspicuous. Hindi or regional-language text can appear, but never as a substitute. (Products also regulated as drugs need Drug Facts labeling and specific warnings instead.)
Claims review. This is where Indian brands get hurt most. Claims that are normal in Ayurvedic marketing — “treats eczema,” “heals damaged skin,” “promotes hair growth,” “cures dandruff” — are drug claims in the U.S., judged by intended use as read from your label, listing copy, and ads. See Is Your Product a Cosmetic or a Drug?.
For the detailed labeling changes MoCRA introduced, see MoCRA Labeling Changes.
The pitfalls that catch Indian brands specifically
- The Ayurvedic positioning trap. Ayurveda is a respected medical tradition in India and a marketing asset in the U.S. — but it is not a U.S. legal category. The moment your hair oil “stimulates growth” or your cream “treats” a condition, FDA treats the product as an unapproved drug. You can sell the same formula as a cosmetic with cosmetic claims — but not keep drug claims on a cosmetic filing.
- Skin-lightening lines. Fairness and skin-lightening products are a major Indian category — and a major U.S. enforcement target. FDA scrutinizes them for mercury and hydroquinone, detains shipments at the port, and treats products intended to alter pigmentation as drugs. If your line includes lightening creams, read FDA Detained Your Cosmetic Shipment? before your first container, not after.
- Heavy metals and traditional eye products. FDA has repeatedly flagged lead in traditional products, and kohl-style kajal faces a specific problem: U.S. color additives must be FDA-approved for their intended use, and lead-based eye products are not permitted. Henna is approved only for hair use, not skin application — a real issue for mehndi-positioned products.
- Assuming a marketplace listing means compliance. Many Indian brands sell on Amazon USA and assume a live listing means the regulatory side is handled. It does not: Amazon’s checks are Amazon’s, and FDA’s requirements apply regardless. See Selling Cosmetics on Amazon: FDA Requirements.
- Small-business exemption confusion. The U.S. small-business exemption (Section 612 of the FD&C Act, 21 U.S.C. section 364h) is based on U.S. sales, not Indian turnover, and it never exempts labeling, safety substantiation, or adverse event reporting. Check the exemption worksheet rather than assuming.
- Forgetting the ongoing duties. Registration is not a one-time event: biennial renewal, annual listing updates, adverse event reporting within 15 business days for serious events, and records kept for six years that FDA can demand to see. See MoCRA Adverse Event Reporting.
A realistic India-to-US launch sequence
- Classify every product as cosmetic or drug for the U.S. market (re-do the claims first — this decides everything else).
- Confirm whether you qualify for the small-business exemption; if not, proceed with full compliance.
- Request your facility’s FEI number (7 to 10 business days).
- Choose and appoint your U.S. agent.
- File facility registration via Cosmetics Direct.
- File product listings.
- Finalize U.S.-compliant labels before the first shipment.
- Set up adverse event intake and record-keeping from day one.
For realistic timing on each step, see How Long Does MoCRA Facility Registration Take?.
FAQ
Does my AYUSH or CDSCO licence count for anything in the US?
No. Indian licences have no standing with FDA, the U.S. has no Ayurvedic category, and your registration, agent, listings, and labels must all be done under MoCRA regardless.
Are Ayurvedic products cosmetics or drugs in the US?
It depends on the claims, not the ingredients or the tradition behind them. A hair oil marketed to “beautify” or “condition” is a cosmetic. The same oil marketed for hair growth or dandruff treatment is a drug and needs a different pathway.
Do I need a U.S. agent if I only sell on Amazon?
Yes, if your products are manufactured outside the U.S. The foreign manufacturing facility must designate its own U.S. agent as part of facility registration, whatever your sales channel.
Are Indian cosmetic labels acceptable in the US?
Usually not without changes. Net quantity declarations, the domestic adverse-event contact, name and place of business, warning statements, and claims all need review against U.S. requirements. Ingredient nomenclature mostly transfers, but formatting rules differ.
How long does the whole process take for an Indian brand?
The FEI request alone takes 7 to 10 business days, and gathering registration details, appointing an agent, and finalizing labels adds more time. Plan for several weeks minimum from a standing start; see How Long Does MoCRA Facility Registration Take? for the full breakdown.
Next step: Indian brand planning a U.S. launch? Contact us for a straight assessment of what your products need, or run the free FEI check to confirm whether your facility already has an FDA Establishment Identifier.
This article is for educational purposes only and is not legal advice. US MoCRA Agent is a private service provider and is not affiliated with or endorsed by the FDA.
